Analyst Coverage and Price Target: Needham initiated coverage of Streamex (NasdaqCM:STEX) with a Buy recommendation, projecting a 145.19% upside based on an average one-year price target of $10.20/share, up from a closing price of $4.16/share.
Fund Sentiment: There has been a significant increase in institutional interest in Streamex, with 55 funds reporting positions, a 48.65% increase in ownership, and a total of 17,600K shares owned, reflecting a bullish outlook indicated by a put/call ratio of 0.55.
Shareholder Activity: Legacy Wealth Management and Legacy Investment Solutions have adjusted their holdings, with the former increasing its shares by 9.03% and the latter by 47.31%, while also significantly increasing its portfolio allocation.
Fintel Overview: Fintel provides comprehensive investing research tools, including fundamentals, analyst reports, and fund sentiment, aimed at individual investors and small hedge funds to enhance investment decisions.
Wall Street analysts forecast STEX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for STEX is 12.00 USD with a low forecast of 12.00 USD and a high forecast of 12.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
Wall Street analysts forecast STEX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for STEX is 12.00 USD with a low forecast of 12.00 USD and a high forecast of 12.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 3.120
Low
12.00
Averages
12.00
High
12.00
Current: 3.120
Low
12.00
Averages
12.00
High
12.00
Needham
NULL -> Buy
initiated
$12
Al Analysis
2025-11-25
Reason
Needham
Price Target
$12
Al Analysis
2025-11-25
initiated
NULL -> Buy
Reason
Needham initiated coverage of Streamex with a Buy rating and $12 price target. Streamex is an early mover in the fast-growing market for tokenized real-world assets, launching with GLDY, a tokenized gold product offering roughly 4% yield and potential to exceed $1B in issuance, the analyst tells investors in a research note. The company benefits from strong distribution partners, a differentiated product, and significant operating leverage as the platform scales, the firm says.
About STEX
Streamex Corp., formerly BioSig Technologies, Inc., is a real world asset (RWA) tokenization company. The Company with institutional grade infrastructure brings the gold and commodities market on chain, enabled by a gold denominated treasury and tokenization technology powering the modern commodities market. The Company is a wholly owned subsidiary of BioSig Technologies, Inc.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
